Journal Mobile Options
Table of Contents
Vol. 11, No. 3, 2000
Issue release date: May–June 2000
Dement Geriatr Cogn Disord 2000;11:147–152

A 2-Year Follow-Up of Behavioural and Psychological Symptoms in Alzheimer’s Disease

Haupt M. · Kurz A. · Jänner M.
aPsychiatrische Klinik der Heinrich-Heine-Universität Düsseldorf, und bPsychiatrische Klinik der Technischen Universität München, Deutschland

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Background: The aim was to examine the longitudinal occurrence and persistence of behavioural and psychological symptoms of dementia (BPSD) in Alzheimer’s disease (AD). Methods: Following 60 patients with mild to severe AD over a period of 2 years with annual evaluations, the prospective occurrence and persistence of BPSD in AD were determined by using the Behavioural Abnormalities in AD Rating scale (BEHAVE-AD). Clinical and demographic features of the AD patients were analysed for their association with course features of these symptoms. Results: All of the 60 AD patients experienced BPSD at some point during the 2-year period, particularly agitation was present in every patient within this period. 2-year persistence of BPSD in AD was frequently observed in patients with agitation and with depressiveness, with less frequency in patients with anxiety and aggressiveness, but not in patients with delusions or hallucinations. 2-year persistent aggressiveness was associated with older age and more functional impairment. More functional impairment was also related to 2-year non-persistent hallucinations. Conclusions: Counselling AD patients and their families and tailoring therapeutic strategies should take into account the different modi of BPSD in AD occurring and persisting longitudinally and interacting with functional disturbances.

Copyright © 2000 S. Karger AG, Basel

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Wragg R, Jeste D: Overview of depression and psychosis in Alzheimer’s disease. Am J Psychiatry 1989;146:577–587.
  2. IPA: Behavioural and Psychological Signs and Symptoms in Dementia (BPSSD): Implications for research and treatment. Int Psychogeriatr 1996;8(suppl 3):215–552.
  3. Haupt M, Kurz A: Predictors of nursing home placement in patients with Alzheimer’s disease. Int J Geriatr Psychiatry 1993;8:741–747.
  4. Folstein MF, Bylsma B: Treatment of noncognitive symptoms; in Terry RD, Katzman R, Bick KL (eds): Alzheimer Disease. London, Raven Press, 1994, pp 27–40.
  5. Haupt M: Psychotherapeutic intervention in dementia. Dementia 1996;7:207–210.
  6. Haupt M, Jänner M, Ebeling S, et al: Presentation and stability of noncognitive symptom patterns in patients with Alzheimer’s disease. Alzheimer Dis Assoc Disord 1998;12:323–329.
  7. Rubin E, Drevets W, Burke WJ: The nature of psychotic symptoms in senile dementia of the Alzheimer type. J Geriatr Psychiatry Neurol 1988;1:16–20.

    External Resources

  8. Stern Y, Mayeux R, Sano M, et al: Predictors of disease course in patients with probable Alzheimer’s disease. Neurology 1987;37:1649–1653.
  9. Rosen J, Zubenko GS: Emergence of psychosis and depression in the longitudinal evaluation of Alzheimer’s disease. Biol Psychiatry 1991;29:224–232.
  10. Jeste DV, Lacro JP, Gilbert PL, et al: Treatment of late-life schizophrenia with neuroleptics. Schizophr Bull 1993;19:817–830.
  11. Ballard CG, Patel A, Solis M; et al: A one-year follow-up study of depression in dementia sufferers. Br J Psychiatry 1996;168:287–291.
  12. Ballard CG, O’Brien J, Coope B, et al: A prospective study of psychotic symptoms in dementia sufferers: Psychosis in dementia. Int Psychogeriatr 1997;9:57–64.
  13. Devanand DP, Jacobs DM, Tang M-X, et al: The course of psychopathological features in mild to moderate Alzheimer disease. Arch Gen Psychiatry 1997;54:257–263.
  14. Starkstein SE, Chemerinski E, Sabel L, et al: Prospective longitudinal study of depression and anosognosia in Alzheimer’s disease. Br J Psychiatry 1997;171:47–52.
  15. Roth M, Tym E, Mountjoy CQ, et al: CAMDEX. A standardized instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986;149:698–709.
  16. Folstein MF, Folstein SE, Hughes PR: Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975;12:189–198.
  17. Blessed G, Tomlinson BE, Roth M: The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968;114:797–811.
  18. Reisberg B, Borenstein J, Franssen E, et al: BEHAVE-AD: A clinical rating scale for the assessment of psychopharmacologically remediable behavioral symptomatology in Alzheimer’s disease; in Altman HJ (eds): Alzheimer’s Disease: Problems, Prospects, and Perspectives. New York, Plenum Press, 1987, pp 1–16.
  19. Sclan CG, Saillon A, Franssen E, et al: BEHAVE-AD: Reliability and analysis of symptom category scores. Int J Geriatr Psychiatry 1996;11:423–430.

    External Resources

  20. Chandler JD, Chandler JE: The prevalence of neuropsychiatric disorders in a nursing home population. J Geriatr Psychiatry Neurol 1988;1:71–76.

    External Resources

  21. Devanand DP, Brockington CD, Moody BJ, et al: Behavioral syndromes in Alzheimer’s disease. Int Psychogeriatr 1992;4:161–184.

    External Resources

  22. Birkett DP: The psychiatric differentiation of senility and arteriosclerosis. Br J Psychiatry 1972;120:321–325.

    External Resources

  23. Knesevich JW, Martin RL, Berg L, et al: Preliminary report on affective symptoms in early stage of senile dementia of the Alzheimer type. Am J Psychiatry 1983;140:233–235.

    External Resources

  24. Patel V, Hope T: Aggressive behaviour in elderly people with dementia: A review. Int J Geriatr Psychiatry 1993;8:457–472.
  25. Aarsland D, Cummings JL, Yenner G, et al: Relationship of aggressive behavior to other neuropsychiatric symptoms in patients with Alzheimer’s disease. Am J Psychiatry 1996;153:243–247.
  26. Rabins PV: Noncognitive symptoms in Alzheimer’s disease; in Terry RD, Katzman R, Bick KL (eds): Alzheimer Disease. London, Raven Press, pp 419–429.
  27. Coen RF, Suranwick GR, O’Boyle C, et al: Behaviour disturbance and other predictors of carer burden in Alzheimer’s disease. Int J Geriatr Psychiatry 1997;12:331–336.
  28. Steele C, Rovner B, Chase GA, et al: Prospective longitudinal study of depression and anosognosia in Alzheimer’s disease. Am J Psychiatry 1990;147:1049–1051.
  29. Hinchliffe AC, Hyman IL, Blizard B: Behavioural complications of dementia – Can they be treated? Int J Geriatr Psychiatry 1995;10:839–847.
  30. Mittelman MS, Ferris SH, Steinberg G, et al: An intervention that delays institutionalization of Alzheimer’s disease patients: Treatment of spouse-caregivers. Gerontologist 1993;33:730–740.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50